Literature DB >> 4823101

Editorial: Rifampin in the treatment of tuberculosis.

S Grzybowshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4823101      PMCID： PMC1947757     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations.

Authors:  R Pallanza; V Arioli; S Furesz; G Bolzoni
Journal:  Arzneimittelforschung       Date:  1967-05

2.  Rifampin in initial treatment of pulmonary tuberculosis. A.U.S. Public Health Service tuberculosis therapy trial.

Authors:  R Newman; B E Doster; F J Murray; S F Woolpert
Journal:  Am Rev Respir Dis       Date:  1974-02

Review 3.  Rifampin.

Authors:  M Schonell; E Dorken; S Grzybowski
Journal:  Can Med Assoc J       Date:  1972-04-08       Impact factor: 8.262

4.  Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol.

Authors:  C W Jeanes; A G Jessamine; L Eidus
Journal:  Can Med Assoc J       Date:  1972-04-22       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.